Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06602141

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
AdventHealth Translational Research Institute · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to study the effects of endurance exercise training on adipose (fat) tissue quality and insulin sensitivity in men and women.

Conditions

Interventions

TypeNameDescription
PROCEDUREMuscle BiopsyThis procedure is used to sample muscle cells from the leg Vastus Lateralis (thigh) muscle.
PROCEDUREAdipose BiopsyThis procedure is used to sample fat tissue from the abdomen (belly).
OTHERGlucose ClampIn this test, we will measure the effect of insulin by giving you insulin and glucose (sugar) intravenously through an IV line in your arm.
OTHERAccelerometerThe tri-axial accelerometer measure activity and uses those values to estimate the number of calories burned based on your height, weight, age, and gender. The monitor also evaluates physical effort and the body's response to different activities.
OTHEREndurance ExerciseVisit the study site 3 times a week to engage in endurance exercise training for approximately 12 weeks. Each session will last approximately 75 minutes, and exercise group can choose to use either a stationary bike or a treadmill to complete the training.
OTHERPhysical activity/ dietary habitsVisit the study site bi-weekly to get weight measurements and speak to the study team about weight maintenance and participant physical activity/dietary habits.
OTHERHeavy Water Labeling PeriodParticipants in both control groups will be required to drink heavy water, which is ordinary water that is enriched with deuterium (stable, non-radioactive isotope) and called deuterium-labeled water, for 12 weeks.

Timeline

Start date
2024-09-11
Primary completion
2029-04-01
Completion
2029-04-01
First posted
2024-09-19
Last updated
2026-03-27

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06602141. Inclusion in this directory is not an endorsement.